Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 22 (abbreviated H3P22) is classified as a pseudogene related to the histone H3 family. Pseudogenes are genetic elements that resemble protein-coding genes but typically lack the ability to produce functional proteins due to mutations or truncations. The name implies homology with the canonical histone H3 family, whose functional members (such as H3.1, H3.2, and the variant H3.3) are core structural proteins involved in chromatin organization, epigenetic regulation, and DNA packaging in all eukaryotic cells[1][2][3]. However, H3 histone pseudogene 22 itself does not encode a functional histone protein and is not represented among active histone genes or variants described in comprehensive reviews of the H3 gene family[1][2][3]. There is no established biological function, disease association, or therapeutic relevance for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 22 (H3P22).